Plain-English translation of NCT07412314 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing proton therapy, an advanced form of radiation treatment that targets tumors more precisely than standard radiation. Proton therapy works by directing a high-energy beam directly at the cancer cells, releasing its full power right at the tumor site—like a directed explosion—while minimizing damage to healthy tissues around it. This study is for patients with nasopharynx cancer that has come back after their initial treatment.
Standard radiation treatment (called IMRT) has helped many patients with recurrent nasopharynx cancer, but survival rates remain low and many patients experience severe side effects like tissue death in the treated area. Researchers are testing this newer, more precise form of radiation to see if it can improve survival while reducing these harmful side effects.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive proton therapy as your radiation treatment. The therapy will be delivered over 6 to 6.5 weeks, with five treatment sessions per week, and each course will consist of 30 to 33 sessions total. Before treatment begins, your doctors will evaluate your tumor to plan the exact dose and target area. Throughout the trial, your medical team will monitor how you are responding and watch for any side effects.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
China